Know Your Market Before You Enter It
Commercial, regulatory, and competitive intelligence for life sciences and consumer health companies expanding globally.
The Intelligence Layer Between Ambition and Action
Market intelligence is the systematic gathering, analysis, and interpretation of data about a market — its size, growth, competitive dynamics, regulatory environment, and commercial landscape — to enable informed strategic decisions.
At Taevas, we go beyond desk research. Our intelligence combines primary expert interviews, proprietary databases, regulatory filings, and commercial analytics to give you a complete picture of your opportunity — before you commit capital or resources.
Board-ready intelligence that de-risks decisions and accelerates market entry.
Primary Research
KOL interviews, regulator consultations, channel partner dialogues
Proprietary Data
Regulatory filings, clinical databases, commercial analytics
Custom Modelling
TAM/SAM/SOM projections, scenario planning, sensitivity analysis
Decision Frameworks
Go/no-go criteria, market prioritisation, launch sequencing
Six Pillars of Market Intelligence
Six interconnected dimensions of intelligence — each rigorous on its own, transformative together.
Market Sizing & Forecasting
TAM, SAM, and SOM modelling with 5-year growth projections across therapy areas and geographies.
Regulatory Intelligence
Approval pathways, timelines, and compliance frameworks across FDA, EMA, CDSCO, and 40+ global markets.
Competitive Analysis
Pipeline benchmarking, product positioning, SWOT analysis, and whitespace identification.
Commercial Strategy
Pricing benchmarks, reimbursement landscape, market access pathways, and launch readiness assessment.
Geographic Opportunity Mapping
Market prioritisation based on demand signals, competitive intensity, and regulatory ease-of-entry.
Analytics Dashboards
Interactive visualisations synthesising intelligence into executive-ready decision frameworks.
From Brief to Board-Ready Intelligence
A structured four-stage process that balances speed with rigour — typically complete in 4–6 weeks.
Scope & Brief
What Happens
We align on objectives, geographies, therapy areas, and the specific business questions that need answering.
A 30–45 minute scoping call establishes the intelligence framework — ensuring every subsequent research hour is focused on decisions that matter.
Sector-Specific Expertise
Intelligence calibrated to the unique regulatory, commercial, and competitive dynamics of your sector.
Pharmaceutical Markets
From branded generics to biologics, we cover the full pharmaceutical value chain — clinical pipeline tracking, patent cliff analysis, and reimbursement modelling across regulated and emerging markets.
120+ Countries. Every Major Region.
Deep-dive intelligence across all major pharmaceutical, medtech, and consumer health markets worldwide.
Asia Pacific
India · China · Japan · South Korea · Australia · Indonesia · Thailand · Vietnam · Philippines
Europe
Germany · France · UK · Italy · Spain · Netherlands · Switzerland · Poland · Sweden
Americas
United States · Canada · Brazil · Mexico · Colombia · Argentina · Chile
Middle East
UAE · Saudi Arabia · Turkey · Israel · Egypt · Qatar
Africa
South Africa · Nigeria · Kenya · Ethiopia · Morocco
South Asia
Bangladesh · Sri Lanka · Pakistan · Nepal · Myanmar
Everything in Every Report
Comprehensive deliverables designed for board-level decisions — not just background reading.
Market Sizing & Forecast Model
TAM/SAM/SOM with 5-year projections, segmented by product type, end user, and geography.
Competitive Landscape Report
Profiling of top 10–15 players with pipeline, financials, positioning, and SWOT analysis.
Regulatory Pathway Summary
Step-by-step approval guide, typical timelines, required dossiers, and local partner requirements.
Pricing & Reimbursement Analysis
Benchmark pricing across channels, reimbursement eligibility, and HTA decision landscape.
Market Entry Recommendation
Prioritised strategy with recommended partnerships, channels, and launch sequencing.
Stakeholder & KOL Map
Key opinion leaders, payer organisations, and the distributor ecosystem across target markets.
Executive Dashboard
Interactive data visualisation summarising findings for C-suite and board presentations.
30-Day Q&A Support
Post-delivery support to clarify findings, run scenario analyses, or refine recommendations.
Built for Decision-Makers
Whether you're validating a new geography or preparing a board-level market entry case — we have a format that fits.
Pharma & Medtech Companies
Evaluating new market entry, product launches in new geographies, or acquisitions requiring deep commercial due diligence.
Investors & PE Funds
Conducting commercial due diligence, validating market size assumptions, or assessing competitive moats before committing capital.
Startups & Scale-Ups
Seeking investor-grade market data to underpin fundraising narratives, identify first-mover opportunities, or prioritise expansion.
Government & Trade Bodies
Understanding sector landscapes, benchmarking policy environments, and identifying foreign investment opportunities in health and life sciences.
Research Institutions
Translating academic research into commercial potential assessments, technology transfer opportunities, and licensing strategy.
Consultancies & Agencies
White-label intelligence support for strategy and management consulting firms advising clients across life sciences markets.
What Sets Our Intelligence Apart
Sector Depth, Not Generalism
Our analysts work exclusively in pharma, medtech, and consumer health. Every report reflects deep domain expertise — not generic research methodology applied to healthcare.
Primary Research at the Core
We don't just aggregate public data. Every engagement includes primary interviews with regulators, KOLs, payers, and channel partners — intelligence you can't Google.
Emerging Market Coverage
Our network spans India, Southeast Asia, MENA, and Sub-Saharan Africa — markets that generic firms cover superficially but where the greatest growth opportunities exist.
Decision-Ready Format
We write for decision-makers, not archives. Every report includes a clear recommendation. Our readout sessions are structured for board discussions, not just information transfer.
Speed Without Compromise
Rapid-response turnarounds of 2–4 weeks for focused engagements — without sacrificing the rigour of primary research and expert validation.
Continued Partnership
Our 30-day Q&A window, ongoing subscriptions, and retainer models mean we're a long-term intelligence partner — not a one-off vendor.
“Taevas gave us the confidence to enter the Indian market two quarters ahead of schedule. Their intelligence didn't just answer our questions — it showed us the questions we hadn't thought to ask.”
Extend Your Intelligence
Market intelligence is the starting point. Pair it with our complementary services to go from insight to action.
Regulatory Strategy & Dossier Support
From regulatory pathway mapping to full dossier preparation and submission management across global markets.
Partner & Distributor Identification
Shortlisting, evaluating, and connecting you with validated in-market partners, distributors, and licensing candidates.
Pricing & Market Access Strategy
Optimise launch pricing, reimbursement positioning, and access pathways to maximise commercial success from day one.
Medical Affairs & KOL Engagement
Scientific communication strategy, publication planning, and structured KOL engagement programmes for new market entrants.
Commercial Due Diligence
Investor-grade commercial assessments for M&A, licensing deals, or fundraising — with rapid turnaround for live transactions.
Ongoing Intelligence Subscriptions
Monthly or quarterly market monitoring — competitive signals, regulatory updates, and commercial developments as a managed service.
Frequently Asked Questions
Ready to Enter Your Next Market with Confidence?
Tell us your target market and product category. We'll scope a custom intelligence project within 48 hours.